Literature DB >> 19939924

Tpl2/AP-1 enhances murine gammaherpesvirus 68 lytic replication.

Xudong Li1, Jun Feng, Shijia Chen, Li Peng, Wei-Wu He, Jing Qi, Hongyu Deng, Ren Sun.   

Abstract

How cellular factors regulate gammaherpesvirus lytic replication is not well understood. Here, through functional screening of a cellular kinase expression library, we identified mitogen-activated protein kinase kinase kinase 8 (MAP3K8/Tpl2) as a positive regulator of murine gammaherpesvirus 68 (MHV-68 or gammaHV-68) lytic gene expression and replication. Tpl2 enhances MHV-68 lytic replication by upregulating lytic gene expression and promoter activities of viral lytic genes, including RTA and open reading frame 57 (ORF57). By screening a cellular transcription factor library, we identified the Fos AP-1 transcription factor as a downstream factor that is both necessary and sufficient for mediating the enhancement of MHV-68 lytic replication by Tpl2. In addition, Tpl2 stimulates the promoter activities of key viral lytic genes, including RTA and ORF57, in an AP-1-dependent manner. We identified an AP-1-responsive element on the MHV-68 RTA promoter as the cis element mediating the upregulation of RTA promoter activity by Tpl2. MHV-68 lytic infection upregulates Fos expression, AP-1 activity, and RTA promoter activity in a Tpl2-dependent manner. We constructed a mutant MHV-68 virus that abolished this AP-1-responsive element. This mutant virus exhibited attenuated lytic replication kinetics, indicative of a critical role of this AP-1-responsive element during lytic replication. Moreover, Tpl2 knockdown inhibited the lytic replication of wild-type MHV-68 (MHV-68-WT) but not that of the MHV-68 mutant virus, indicating that endogenous Tpl2 promotes efficient virus lytic replication through AP-1-dependent upregulation of RTA expression. In summary, through tandem functional screens, we identified the Tpl2/AP-1 signaling transduction pathway as a positive regulator of MHV-68 lytic replication.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19939924      PMCID: PMC2812393          DOI: 10.1128/JVI.01856-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  64 in total

1.  Poly(ADP-ribose) polymerase 1 and Ste20-like kinase hKFC act as transcriptional repressors for gamma-2 herpesvirus lytic replication.

Authors:  Yousang Gwack; Hiroyuki Nakamura; Sun Hwa Lee; John Souvlis; Jason T Yustein; Steve Gygi; Hsing-Jien Kung; Jae U Jung
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

2.  Activation of herpes simplex virus 1 gamma 2 genes by viral DNA replication.

Authors:  P Mavromara-Nazos; B Roizman
Journal:  Virology       Date:  1987-12       Impact factor: 3.616

3.  Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA.

Authors:  J Countryman; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

4.  Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins.

Authors:  R W Honess; B Roizman
Journal:  J Virol       Date:  1974-07       Impact factor: 5.103

5.  Viral DNA synthesis is required for the efficient expression of specific herpes simplex virus type 1 mRNA species.

Authors:  L E Holland; K P Anderson; C Shipman; E K Wagner
Journal:  Virology       Date:  1980-02       Impact factor: 3.616

6.  Phosphorylation of the carboxyl-terminal transactivation domain of c-Fos by extracellular signal-regulated kinase mediates the transcriptional activation of AP-1 and cellular transformation induced by platelet-derived growth factor.

Authors:  Paula Monje; Maria Julia Marinissen; J Silvio Gutkind
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

7.  Transcription program of murine gammaherpesvirus 68.

Authors:  DeeAnn Martinez-Guzman; Tammy Rickabaugh; Ting-Ting Wu; Helen Brown; Steven Cole; Moon Jung Song; Leming Tong; Ren Sun
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling.

Authors:  Yuying Liang; Don Ganem
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-27       Impact factor: 11.205

9.  NF-kappaB inhibits gammaherpesvirus lytic replication.

Authors:  Helen J Brown; Moon Jung Song; Hongyu Deng; Ting-Ting Wu; Genhong Cheng; Ren Sun
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

10.  Early activation of the Kaposi's sarcoma-associated herpesvirus RTA, RAP, and MTA promoters by the tetradecanoyl phorbol acetate-induced AP1 pathway.

Authors:  Shizhen Emily Wang; Frederick Y Wu; Honglin Chen; Meir Shamay; Qizhi Zheng; Gary S Hayward
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

View more
  10 in total

1.  Tiled microarray identification of novel viral transcript structures and distinct transcriptional profiles during two modes of productive murine gammaherpesvirus 68 infection.

Authors:  Benson Yee Hin Cheng; Jizu Zhi; Alexis Santana; Sohail Khan; Eduardo Salinas; J Craig Forrest; Yueting Zheng; Shirin Jaggi; Janet Leatherwood; Laurie T Krug
Journal:  J Virol       Date:  2012-02-08       Impact factor: 5.103

2.  Gammaherpesvirus gene expression and DNA synthesis are facilitated by viral protein kinase and histone variant H2AX.

Authors:  Bryan C Mounce; Fei Chin Tsan; Lindsay Droit; Sarah Kohler; Justin M Reitsma; Lisa A Cirillo; Vera L Tarakanova
Journal:  Virology       Date:  2011-09-22       Impact factor: 3.616

3.  Tpl2 inhibitors thwart endothelial cell function in angiogenesis and peritoneal dissemination.

Authors:  Wen-Jane Lee; Keng-Hsin Lan; Chiang-Ting Chou; Yu-Chiao Yi; Wei-Chih Chen; Hung-Chuan Pan; Yen-Chun Peng; Keh-Bin Wang; Yi-Ching Chen; Te-Hsin Chao; Hsing-Ru Tien; Wayne Huey Herng Sheu; Meei-Ling Sheu
Journal:  Neoplasia       Date:  2013-09       Impact factor: 5.715

4.  Amplification of JNK signaling is necessary to complete the murine gammaherpesvirus 68 lytic replication cycle.

Authors:  James A Stahl; Clinton R Paden; Shweta S Chavan; Veronica MacLeod; Ricky D Edmondson; Samuel H Speck; J Craig Forrest
Journal:  J Virol       Date:  2012-09-26       Impact factor: 5.103

5.  EBV microRNA BART 18-5p targets MAP3K2 to facilitate persistence in vivo by inhibiting viral replication in B cells.

Authors:  Jin Qiu; David A Thorley-Lawson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-10       Impact factor: 11.205

6.  A Human Gain-of-Function STING Mutation Causes Immunodeficiency and Gammaherpesvirus-Induced Pulmonary Fibrosis in Mice.

Authors:  Brock G Bennion; Harshad Ingle; Teresa L Ai; Cathrine A Miner; Derek J Platt; Amber M Smith; Megan T Baldridge; Jonathan J Miner
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

7.  Cdk1 inhibition induces mutually inhibitory apoptosis and reactivation of Kaposi's sarcoma-associated herpesvirus.

Authors:  Xudong Li; Shijia Chen; Ren Sun
Journal:  J Virol       Date:  2012-04-11       Impact factor: 5.103

8.  Oxidative stress induces reactivation of Kaposi's sarcoma-associated herpesvirus and death of primary effusion lymphoma cells.

Authors:  Xudong Li; Jiaying Feng; Ren Sun
Journal:  J Virol       Date:  2010-11-10       Impact factor: 5.103

9.  An integrated approach to elucidate the intra-viral and viral-cellular protein interaction networks of a gamma-herpesvirus.

Authors:  Shaoying Lee; Lukasz Salwinski; Chaoying Zhang; Derrick Chu; Claire Sampankanpanich; Nichole A Reyes; Abbey Vangeloff; Fangfang Xing; Xudong Li; Ting-Ting Wu; Sudhir Sahasrabudhe; Hongyu Deng; Douglas J Lacount; Ren Sun
Journal:  PLoS Pathog       Date:  2011-10-20       Impact factor: 6.823

10.  Phosphoproteomic analyses reveal signaling pathways that facilitate lytic gammaherpesvirus replication.

Authors:  James A Stahl; Shweta S Chavan; Jeffrey M Sifford; Veronica MacLeod; Daniel E Voth; Ricky D Edmondson; J Craig Forrest
Journal:  PLoS Pathog       Date:  2013-09-19       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.